바로가기메뉴

본문 바로가기 주메뉴 바로가기
 
 

logo

  • ENGLISH
  • P-ISSN3022-6805
  • E-ISSN3022-6791
  • KCI

ISSN : 3022-6805

논문 상세

이전 다음
논문 투고

Vol.3 No.2

PDF Citation Share

Effects of compound traditional Astragalus and Salvia Miltiorrhiza extract on acute and chronic hepatic injury

셀메드 / CELLMED, (P)3022-6805; (E)3022-6791
2013, v.3 no.2, pp.15-15
Yan Yang (Anhui Medical University)
Xiaoxiang Zhang (Hefei University of Technology)
Xin Liu (Princess Alexandra Hospital)
Chao Wu (Anhui Medical University)
Min-Zhu Chen (Anhui Medical University)
Yan, Y. , Xiaoxiang, Z. , Xin, L. , Chao, W. , & Min-Zhu, C. (2013). . , 3(2), 15-15.

Abstract

Previous reports showed that Compound Astragalus and Salvia miltiorrhiza extract (CASE), which was mainly composed of astragalosides, astragalus polysaccharide and salvianolic acids, inhibited hepatic fibrosis by mediating transforming growth factor-β (TGF-β)/Smad signaling. Our aim was to examine the effects of CASE on D-galactosamine (D-GalN) treated liver injury in mice and carbon tetrachloride (CCl4)-induced liver fibrosis in rats. CASE was administered to mice with D-GalN-induced liver injury and to rats with CCl4-induced liver fibrosis, respectively. Liver injury was routinely evaluated by relative liver weight, serum levels of ALT, AST, hyaluronic acid (HA), hepatic malondialdehyde (MDA) content, superoxide dismutase (SOD) activity, hydroxyproline (HYP) and histopathologic changes. Treatment of mice with CASE (60, 120, and 240 mg/kg, ig) significantly lowered ALT, relative liver weight, and MDA levels when compared with D-GalN treated mice. CASE (120, 240 mg/kg) significantly lowered ALT, AST, HA, HYP, and MDA levels against CCl4 treated rats. Decreased SOD level was reversed with CASE treatment. Upon histopathological examination, CASE treatment had significantly inhibitory effect on the progression of hepatic fibrosis in rats. These results indicate that CASE might be effective in treatment and prevention of acute and chronic hepatic injury due to its antioxidant activity.

keywords
compound Astragalus and Salvia miltiorrhiza extract, hepatic injury, antioxidant

참고문헌

1.

Hu S, Chen Li X, Qin R, Mei Z. Antitumor effects of Chi Chi-Shen extract from Salvia miltiorrhiza and Paeoniae radix on human hepatocellular carcinoma cells. Acta Pharmacol Sin. 2007;28:1215-1223

2.

Huang XZ, She SF, Wang GB. Experimental researc of the various doses treatment groups of Salvia miltiorrhiza to prevent liver fibrosis induced with CCl4. Integr. Tradi and West Met J Hepatol. 2001;11:213-215.

3.

Iredale JP, Benyon RC, Pickering J, McCullen M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stelllate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538-549.

4.

Kang H, Ahn KS, Cho C, Bae HS. 2004. Immunomodulatory effect of Astragali Radix extract on murine TH1/TH2 cell lineage development. Biol Pharm Bull. 2004;27:1946-1950.

5.

Karadeniz A, Cemek M, Simsek N. The effects of Panax ginseng and Spirulina platensis on hepatotoxicity induced by cadmium in rats. Ecotoxicol Environ Saf. 2009;72:231-235.

6.

Li C, Luo J, Li L, Cheng M, Huang N, Liu J, Waalkes MP. The collagenolytic effects of the traditional Chinese medicine preparation, Han- Dan-Gan-Le, contribute to reversal of chemical- induced liver fibrosis in rats. Life Sci. 2003;72:1563-1571.

7.

Lin YL, Wu CH, Luo MH, Huang YJ, Wang CN, Shiao MS,Huand YT. In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol. 2006;105:215-222.

8.

Liu J, Shen H, Ong CN. Salvia miltiorrhiza inhibits cell growth and induces apoptosis in human hepatoma HepG2 cells. Cancer Letters 2000;153:85-93

9.

Liu X, Yang Y, Zhang X, Xu S, He S, Huang W, Roberts MS. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-b/Smad in HepG2 cell. J Gastroenterol Hepatol. 2010;25:420-426.

10.

Roxas M, Jurenka J. Colds and influenza: a review of diagnosis and conventional, botanical, and nutritional considerations. Altern Med Rev. 2007;12:25-48.

11.

Shyu MH, Kao TC, Yen GC. Hsian-tsao (Mesona procumbens Heml.) prevents against rat liver fibrosis induced by CCl4 via inhibition of hepatic stellate cells activation. Food Chem Toxicol. 2008;46:3707-3713.

12.

Stachlewitz RF, Seabra V, Bradford B, Bradham CA, Rusyn I, Germolec D, Germolec D, Thurman RG. Glycine and uridine prevent Germolec D, Thurman RG. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells. Hepatology. 1999;29:737

13.

Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis. 1990;10:56-65.

14.

Wu Q, Yang Y, Xue S, Zhang X, Zhou Chen M. Effect of astragalosides on proliferation and collagen production of hepatic stellate cells in vitro. hepatic stellate cells in vitro. 2003;19:892-895

15.

Yang Y, Yang S, Chen M, Zhang X, Zou Y, Zhang X. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts. J Ethnopharmacol. 2008;118:264-270.

16.

Zhang XX, Yang Y, Chen MZ. Effect of total polysaccharide of Astragalus on proliferation and collagen production of HSC-T6 cells. Chin. J. Clin. Pharmacol. Ther (Chin). 2003;8:645-647.

셀메드

논문 투고 OA 정책